Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$7.96 - $16.64 $194,287 - $406,149
-24,408 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$13.16 - $23.68 $321,209 - $577,981
24,408 New
24,408 $387,000
Q4 2021

Feb 14, 2022

SELL
$21.52 - $36.02 $369,498 - $618,463
-17,170 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$27.42 - $48.97 $470,801 - $840,814
17,170 New
17,170 $513,000
Q2 2021

Aug 13, 2021

SELL
$39.41 - $47.25 $355,557 - $426,289
-9,022 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$43.34 - $65.91 $391,013 - $594,640
9,022 New
9,022 $400,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $640M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.